AMSF logo

AMERISAFE, Inc. Stock Price

NasdaqGS:AMSF Community·US$519.0m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

AMSF Share Price Performance

US$27.87
-18.23 (-39.54%)
US$36.67
Fair Value
US$27.87
-18.23 (-39.54%)
24.0% undervalued intrinsic discount
US$36.67
Fair Value
Price US$27.87
AnalystConsensusTarget US$36.67
AnalystHighTarget US$45.00
AnalystLowTarget US$31.00

AMSF Community Narratives

·
Fair Value US$36.67 24.0% undervalued intrinsic discount

AMSF: Financial Tailwinds And Reduced Catastrophe Losses Will Support Share Performance

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$45 38.1% undervalued intrinsic discount

Gig Growth And Safety Enforcement Will Expand Coverage Despite Risks

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$31 10.1% undervalued intrinsic discount

Automation And Aging Workforces Will Weaken Workers Compensation Despite Resilience

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$36.67
24.0% undervalued intrinsic discount
Revenue
4.45% p.a.
Profit Margin
8.2%
Future PE
25.24x
Price in 2029
US$42.89
US$31
10.1% undervalued intrinsic discount
Revenue
4.54% p.a.
Profit Margin
8.45%
Future PE
20.65x
Price in 2029
US$36.27
US$45
38.1% undervalued intrinsic discount
Revenue
5.2% p.a.
Profit Margin
9.08%
Future PE
27.37x
Price in 2029
US$53.14

Trending Discussion

No trending discussion available.

Updated Narratives

AMSF logo

AMSF: Underwriting Discipline And Rebased P/E Are Expected To Drive Repricing

Fair Value: US$36.67 24.0% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AMSF logo

AMSF: Higher Discount Rate Assumptions And Margin Pressure Will Shape Future Upside Potential

Fair Value: US$31 10.1% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AMSF logo

AMSF: Premium Growth And Dividend Increases Will Support Future Share Returns

Fair Value: US$45 38.1% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks
2 Rewards

AMERISAFE, Inc. Key Details

US$335.7m

Revenue

US$242.8m

Cost of Revenue

US$92.9m

Gross Profit

US$45.9m

Other Expenses

US$47.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
2.54
27.68%
14.00%
0%
View Full Analysis

About AMSF

Founded
1985
Employees
366
CEO
Gerry Frost
WebsiteView website
www.amerisafe.com

AMERISAFE, Inc., an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. The company was incorporated in 1985 and is based in Deridder, Louisiana.

Recent AMSF News & Updates

Seeking Alpha Aug 07

AMERISAFE: Strong Underwriting, But The Insurance Cycle Is Turning

Summary AMERISAFE specializes in high-risk workers compensation insurance, maintaining profitability through disciplined underwriting and strong client retention above 93%. Despite nine consecutive quarters of premium growth and a 5.5% dividend yield, AMSF faces margin pressure from rising loss ratios and softening insurance rates. Q2 2026 results showed a combined ratio increase to 95.4% and a 17% drop in operating EPS, signaling deteriorating operating trends. With AMSF trading at elevated P/E and P/B multiples versus sector medians, I view the stock as fairly valued and maintain a neutral stance. Read the full article on Seeking Alpha

Recent updates

No updates